[HTML][HTML] Epidemiological characteristics and antibiotic resistance mechanisms of Streptococcus pneumoniae: An updated review

L Li, J Ma, Z Yu, M Li, W Zhang, H Sun - Microbiological Research, 2023 - Elsevier
Streptococcus pneumoniae (S. pneumoniae, pneumococcus) is a Gram-positive bacterium,
which can cause a variety of diseases including otitis media, nasosinusitis, pneumonia …

[HTML][HTML] Use of 15-valent pneumococcal conjugate vaccine among US children: updated recommendations of the Advisory Committee on Immunization Practices …

M Kobayashi - MMWR. Morbidity and mortality weekly report, 2022 - cdc.gov
Use of 15-Valent Pneumococcal Conjugate Vaccine Among US Children: Updated
Recommendations of the Advisory Committee on Immunization Practices — United States …

Identifying children likely to benefit from antibiotics for acute sinusitis: a randomized clinical trial

N Shaikh, A Hoberman, TR Shope, JH Jeong… - JAMA, 2023 - jamanetwork.com
Importance The large overlap between symptoms of acute sinusitis and viral upper
respiratory tract infection suggests that certain subgroups of children being diagnosed with …

Acute otitis media pneumococcal disease burden and nasopharyngeal colonization in children due to serotypes included and not included in current and new …

M Pichichero, R Malley, R Kaur, R Zagursky… - Expert review of …, 2023 - Taylor & Francis
Introduction Despite the introduction of effective pneumococcal conjugate vaccines (PCV),
Streptococcus pneumoniae remains a major cause of acute otitis media (AOM) worldwide …

[HTML][HTML] Suicides among American Indian or Alaska native persons—national violent death reporting system, United States, 2015–2020

D Stone - MMWR. Morbidity and Mortality Weekly Report, 2022 - cdc.gov
Suicides Among American Indian or Alaska Native Persons — National Violent Death
Reporting System, United States, 2015–2020 | MMWR Skip directly to site content Skip directly …

Incidence of acute otitis media in children in the United States before and after the introduction of 7-and 13-valent pneumococcal conjugate vaccines during 1998 …

T Hu, N Done, T Petigara, S Mohanty, Y Song… - BMC Infectious …, 2022 - Springer
Background Acute otitis media (AOM) is a leading cause of office visits and antibiotic
prescriptions in children. Pneumococcal conjugate vaccines were introduced in the USA in …

Estimating the cost-effectiveness of switching to higher-valency pediatric pneumococcal conjugate vaccines in the United Kingdom

M Wilson, A Lucas, D Mendes, A Vyse, B Mikudina… - Vaccines, 2023 - mdpi.com
Currently, the 13-valent pneumococcal conjugate vaccine (PCV13) is administered under a
1+ 1 (1 primary dose) pediatric schedule in the United Kingdom (UK). Higher-valency PCVs …

Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States

N Prasad, C Stoecker, W Xing, BH Cho, AJ Leidner… - Vaccine, 2023 - Elsevier
Background Although use of the 13-valent pneumococcal conjugate vaccine (PCV13)
among children has reduced incidence of pneumococcal disease, a considerable burden of …

Cost-effectiveness analysis of routine use of 15-valent pneumococcal conjugate vaccine in the US pediatric population

M Huang, T Hu, J Weaver, K Owusu-Edusei, E Elbasha - Vaccines, 2023 - mdpi.com
This study evaluated the clinical and economic impact of routine pediatric vaccination with
the 15-valent pneumococcal conjugate vaccine (PCV15, V114) compared with the 13-valent …

New insights into the treatment of acute otitis media

RE El Feghaly, A Nedved, SE Katz… - Expert review of anti …, 2023 - Taylor & Francis
Introduction Acute otitis media (AOM) affects most (80%) children by 5 years of age and is
the most common reason children are prescribed antibiotics. The epidemiology of AOM has …